The newly granted invention patent involves a revolutionary method for antigen-antibody detection. This technique manipulates the dynamic behavior of particles in biological samples by applying specific alternating current signals on a microelectrode array, significantly enhancing the speed and sensitivity of detection. Using this technology, the detection time for bioaffinity reactions has been reduced from tens of minutes or several hours to just a few seconds to one minute, while also increasing detection sensitivity by 3-7 orders of magnitude.     

Dr. Liu Xiaozhu, founder and Chief Technical Officer of MMC, shared: 'Our team has achieved rapid and efficient detection of antibodies and antigens through innovative particle manipulation technology. This breakthrough not only improves the efficiency of medical diagnostics but also expands the application range of the technology, making it widely applicable in the fields of biomedical and chemical testing.

The MMC's innovative products and technologies have been utilized by more than 20 authoritative institutions worldwide and have received 'internationally advanced' ratings in numerous domestic and international evaluations. Our company continues to expand its research and commercialization efforts in the areas of biosensors, biochips, and customized instruments.

With the grant of the new patent, We plan to further promote the application of its technology in global markets, while actively participating in the standardization process to ensure high standards and wide recognition of the technology. Through continuous innovation and commercialization efforts, our company is committed to providing more efficient and accurate biochemical testing solutions to global business partners.